Overview
- 2 public-safe observations are available for this inspection.
- 2 structured CFR citations are represented.
- 2 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
13 Sep 2018
21 CFR 1.504(a)
Hazard analysis written
Cited by Melody M Ragasa Leong, Melody M Ragasa-Leong
13 Sep 2018
21 CFR 1.505(b)
Supplier approval - document
Cited by Melody M Ragasa Leong, Melody M Ragasa-Leong
Inspected site
ASAkshar Sales LLCFremont, United States
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 1.504(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1.505(b) | Cited across public-safe Form 483 observations | 1x |
Full 483 report
Get the verbatim text of all 2 observations
Every observation in full, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere